semaglutide and creatinine lowers UACR in overweight CKD patients Semaglutide in kidney outcomes Obesity

With an estimated 1,000,000 and 3,000,000 Americans impacted , and 25% of which are disabled and unable to work, this diagnosis can be devastating for many of our patients. Theres more hope than just managing POTS symptoms, though

In addition to Mediterranean dietary interventions, the integration of exercise and behavioral modifications in new pharmacotherapy protocols needs to be considered for their potential to enhance both the achievement and maintenance of reduced body weight

et al., Nat

Injectable BPC-157: Which Form Works Best for Healing and Recovery

GIP receptor activation further enhances insulin secretion and may play a role in fat metabolism and energy storage, complementing the effects of GLP-1

If you came to me and had high blood pressure and I put you on a medicine, once your blood pressure got normal, would you stop taking it